Manufacturing
Overview
Biotexus’s quick expansion in the pharmaceutical business is due to its well-planned and state-of-the-art facilities. Infrastructure is essential to a company’s growth and development. Our company’s reputation is founded on manufacturing, research, and development facilities that satisfy worldwide standards and strict quality requirements, ensuring we supply only the best formulas and products.
The production units have been developed to fulfill current worldwide GMP and people safety requirements. Technologies based on platforms.
Transforming oncology and nephrology with innovative medicines, prioritizing patients, quality, affordability, and forging enduring connections through excellence.
Through a targeted therapeutic strategy, we have made significant investments in platform technologies that have resulted in improved medication safety and efficacy. The goal of these investments is to develop distinctive solutions that address the major drawbacks of traditional medication delivery methods while also adding value to existing goods.
Having built technologies in the field of oncological products, we aim to facilitate effective drug delivery across dosage forms
Our manufacturing capital investments help us realise our goal of developing cheap, high-quality medications that meet unmet patient needs. To support our pipeline of complex generics and biotechnology goods, we continue to ramp up capabilities and automation in accordance with our growth plan.
